Shares of Teladoc Health Inc. (NYSE: TDOC) jumped 5.58% in after-hours trading on Tuesday following the release of the company's second quarter 2025 financial results, which exceeded analyst expectations and provided an optimistic outlook for the full year.

The virtual healthcare provider reported a loss of $0.19 per share for Q2, beating the consensus estimate of a $0.25 loss. This represents a significant improvement from the $0.28 per share loss in the same quarter last year. Revenue for the quarter came in at $631.9 million, surpassing analysts' projections of $623.1 million, though slightly down from $642.4 million in Q2 2024.

Teladoc's performance was driven by strong growth in its Integrated Care segment, which saw revenue increase 4% year-over-year to $391.5 million. The company also reported a 11% increase in U.S. Integrated Care Members, reaching 102.4 million at the end of the quarter. Despite a 9% decline in revenue from its BetterHelp segment, Teladoc's overall results and forward guidance appear to have reassured investors about the company's growth trajectory and profitability improvements.

Looking ahead, Teladoc raised its full-year 2025 outlook, projecting revenue between $2.501 billion and $2.548 billion, and adjusted EBITDA of $263 million to $294 million. The company's CEO, Chuck Divita, expressed confidence in Teladoc's strategic direction, stating, "We continue to work with focus and urgency to advance our strategic priorities, invest in products and capabilities, and deliver solid financial performance."